Combination of isocitrate dehydrogenase 1 (IDH1 ) mutation and podoplanin expression in brain tumors identifies patients at high or low risk of venous thromboembolism

C-type lectin-like receptor 2 promotes hematogenous tumor metastasis and prothrombotic state in tumor-bearing mice

(2017) T. Shirai et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Mutant IDH1 and thrombosis in gliomas

(2016) Dusten Unruh et al.   ACTA NEUROPATHOLOGICA

CAR T Cells Targeting Podoplanin Reduce Orthotopic Glioblastomas in Mouse Brains

(2016) S. Shiina et al.   Cancer Immunology Research

Inflammation drives thrombosis after Salmonella infection via CLEC-2 on platelets

(2015) Jessica R. Hitchcock et al.   JOURNAL OF CLINICAL INVESTIGATION

Mutant IDH1 inhibits PI3K/Akt signaling in human glioma

(2014) Peter Birner et al.   CANCER

Biomarkers predictive of venous thromboembolism in patients with newly diagnosed high-grade gliomas

(2014) J. Thaler et al.   NEURO-ONCOLOGY

Coagulation-related gene expression profile in glioblastoma is defined by molecular disease subtype

(2013) N. Magnus et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal

(2013) J. Gao et al.   Science Signaling

Expression of podoplanin in human astrocytic brain tumors is controlled by the PI3K-AKT-AP-1 signaling pathway and promoter methylation

(2012) H. Peterziel et al.   NEURO-ONCOLOGY

Intratumoral tissue factor expression and risk of venous thromboembolism in brain tumor patients

(2012) Johannes Thaler et al.   THROMBOSIS RESEARCH

Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases

(2011) Wei Xu et al.   CANCER CELL

Oncogenic epidermal growth factor receptor up-regulates multiple elements of the tissue factor signaling pathway in human glioma cells

(2010) N. Magnus et al.   BLOOD

Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma

(2010) Houtan Noushmehr et al.   CANCER CELL

Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1

(2010) Roel G.W. Verhaak et al.   CANCER CELL

Epidermal Growth Factor Receptor and PTEN Modulate Tissue Factor Expression in Glioblastoma through JunD/Activator Protein-1 Transcriptional Activity

(2009) Y. Rong et al.   CANCER RESEARCH

High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)

(2008) C. Ay et al.   BLOOD